Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter

Canadian Journal of Emergency Medicine

Volumn 12, Issue 3, 2010, Pages 181-191

  Stiell, Ian G ^a   Clement, Catherine M ^b   Perry, Jeffrey J ^a   Vaillancourt, Christian ^a   Symington, Cheryl ^b   Dickinson, Garth ^a   Birnie, David ^c   Green, Martin S ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Arrhythmias; Atrial fibrillation; Atrial flutter; Cardioversion; Electrical cardioversion; Emergency department

Indexed keywords

AMIODARONE; DILTIAZEM; HEPARIN; METOPROLOL; PROCAINAMIDE; PROPAFENONE; SOTALOL; VERNAKALANT; WARFARIN; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRADYCARDIA; CARDIOVERSION; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COHORT ANALYSIS; EMERGENCY CARE; EMERGENCY PATIENT; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OTTAWA AGGRESSIVE PROTOCOL; PATIENT SAFETY; SINUS RHYTHM; UNIVERSITY HOSPITAL; CANADA; EMERGENCY; MIDDLE AGED; RETROSPECTIVE STUDY; SAFETY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CLINICAL PROTOCOLS; ELECTRIC COUNTERSHOCK; EMERGENCIES; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; ONTARIO; PROCAINAMIDE; RETROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME;

EID: 77956691816     PISSN: 14818035     EISSN: 14818035     Source Type: Journal    
DOI: 10.1017/S1481803500012227     Document Type: Article

References (49)

1. Skanes AC, Dorian P. 2004 Canadian Cardiovascular Society Consensus Conference: Atrial fibrillation - etiology and initial investigation of atrial fibrillation. Can J Cardiol 2005;21:11B-4B.
2. Connors S, Dorian P. Management of supraventricular tachycardia in the emergency department. Can J Cardiol 1997;13(Suppl A):19A-24A.
3. Michael JA, Stiell IG, Agarwal S, et al. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med 1999;33:379-87. (Pubitemid 29157561)
4. Wyse DG, Simpson CS. 2004 Canadian Cardiovascular Society Consensus Conference: atrial fibrillation - rate control versus rhythm control - decision making. Can J Cardiol 2005;21:15B-8B.
5. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 2006;48:149-246.
6. Page RL. Newly diagnosed atrial fibrillation. N Engl J Med 2004;351:2408-16.
7. Hiatt WR, Lincoff M, Harrington RA. Acute pharmacological conversion of atrial fibrillation to sinus rhythm. Is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration. Circulation 2008;117:2956-7.
8. Taylor DM, Aggarwall A, Carter M, et al. Management of new onset atrial fibrillation in previously well patients less than 60 years of age. Emerg Med Australas 2005;17:4-10. (Pubitemid 40227452)
9. Raghavan AV, Decker WW, Meloy TD. Management of atrial fibrillation in the emergency department. Emerg Med Clin North Am 2005;23:1127-39. (Pubitemid 41403274)
10. Burton JH, Vinson DR, Drummond K, et al. Electrical cardioversion of emergency department patients with atrial fibrillation. Ann Emerg Med 2004;44:20-30. (Pubitemid 38864786)
11. Forster AJ. An agenda for reducing emergency department crowding [comment]. Ann Emerg Med 2005;45:479-81. (Pubitemid 40591773)
12. Li G, Lau JT, McCarthy ML, et al. Emergency department utilization in the United States and Ontario, Canada. Acad Emerg Med 2007;14:582-4. (Pubitemid 46755595)
13. Pitts SR, Niska RW, Xu J, et al. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report 2008;6:1-38.
14. Derlet RW, Richards JR. Overcrowding in the nation's emergency departments: complex causes and disturbing effects. Ann Emerg Med 2000;35:63-8. (Pubitemid 30659729)
15. Forster AJ, Stiell IG, Wells GA, et al. The effect of hospital occupancy on emergency department length of stay and patient disposition. Acad Emerg Med 2003;10:127-33. (Pubitemid 36262571)
16. Moskop JC, Sklar DP, Geiderman JM, et al. Emergency department crowding, part 1 - concept, causes, and moral consequences. Ann Emerg Med 2009;53:605-11.
17. Moskop JC, Sklar DP, Geiderman JM, et al. Emergency department crowding, part 2 - barriers to reform and strategies to overcome them. Ann Emerg Med 2009;53:612-7.
18. Decker WW, Smars PA, Vaidyanathan L, et al. A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation. Ann Emerg Med 2008;52:322-8.
19. Klein AL, Grimm RA, Murray D, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-20. (Pubitemid 32402097)
20. Stiell IG, Clement C, Symington C, et al. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. Acad Emerg Med 2007;14:1158-64.
21. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke - results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70.
22. Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community - the Framingham Heart Study. JAMA 2003;290:1049-56. (Pubitemid 37430445)
23. Santini M, De Ferrari GM, Pandozi C, et al. Atrial fibrillation requiring urgent medical care. Approach and outcome in various departments of admission. Data from the atrial fibrillation/flutter Italian registry (FIRE). Ital Heart J 2004;5:205-13.
24. del Arco C, Martin A, Laguna P, et al.; Spanish Atrial Fibrillation in Emergency Medicince Study Group. Analysis of current management of atrial fibrillation in the acute setting: GEFAUR-1 study. Ann Emerg Med 2005;46:424-30.
25. Marx JA, Hockberger RS, Walls RW, et al. Rosen's emergency medicine: concepts and clinical practice, 7th ed. Philadelphia (PA): Mosby; 2010.
26. Wyse DG, Waldo AL, DiMarco JP, et al.; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
27. Epstein AE, Corley SD, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) Study. Circulation 2004;109:1509-13. (Pubitemid 38420179)
28. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008;358:2667-77. (Pubitemid 351860859)
29. Cain ME, Curtis AB. Rhythm control in atrial fibrillation - one setback after another. N Engl J Med 2008;358:2725-7. (Pubitemid 351860867)
30. Joseph AP, Ward MR. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone and digoxin for the reversion of new-onset atrial fibrillation. Ann Emerg Med 2000;36:1-9. (Pubitemid 30641458)
31. Domanovits H, Schillinger M, Thoennissen J, et al. Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion. Resuscitation 2000;45:181-7. (Pubitemid 30665436)
32. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7.3: Management of symptomatic bradycardia and tachycardia. Circulation 2005;112:IV-67-IV-77.
33. Nichol G, McAlister FA, Pham B, et al. Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 2002;87:535-43. (Pubitemid 34547976)
34. Martinez-Marcos FJ, Garcia-Garmendia JL, Ortega-Carpio A, et al. Comparison of intravenous flecainide, propafenone and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 2000;86:950-3.
35. Tijunelis MA, Herbert ME. Myth: Intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome in the emergency department. CJEM 2005;7:262-5.
36. Hilleman DE, Spinler SA. Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. Pharmacotherapy 2002;22:66-74. (Pubitemid 34042389)
37. Chevalier P, Durand-Dubief A, Burri H, et al. Amiodarone versus placebo and classic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003;41:255-62. (Pubitemid 36092194)
38. Letelier LM, Udol K, Ena J, et al. Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis. Arch Intern Med 2003;163:777-85. (Pubitemid 36438049)
39. Miller MR, McNamara RL, Segal JB, et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. J Fam Pract 2000;49:1033-46.
40. Alboni P, Botto GL, Baldi N, et al. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. N Engl J Med 2004;351:2384-91.
41. Roy D, Rowe BH, Stiell IG, et al. A randomized, controlled trial if RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation. J Am Coll Cardiol 2004;44:2355-61. (Pubitemid 39647610)
42. Roy D, Pratt CM, Torp-Pedersen C, et al. Vernakalant hydrochloride for rapid conversion of atrial fibrillation. A phase 3, randomized, placebo-controlled trial. Circulation 2008;117:1518-25.
43. Wyse DG. Initial energy for electrical cardioversion of atrial fibrillation - is more better? Am J Cardiol 2000;86:324-5.
44. de la Morandiere KP, Morriss H. Paddle position in emergency cardioversion of atrial fibrillation. Emerg Med J 2005; 22:44-6. (Pubitemid 40124062)
45. Manning WJ. Strategies for cardioversion of atrial fibrillation - time for a change? [Editorial]. N Engl J Med 2001;344:1468-70. (Pubitemid 32402105)
46. Hylek EM, Evans-Molina C, Shea C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007;115:2689-96. (Pubitemid 46842784)
47. Wyse DG. Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation - from bad to worse. Circulation 2007;115:2684-6. (Pubitemid 46842782)
48. Worster A, Bledsoe RD, Cleve P, et al. Reassessing the methods of medical record review studies in emergency medicine research. Ann Emerg Med 2005;45:448-51. (Pubitemid 43181016)
49. Gilbert EH, Lowenstein SR, Koziol-McLain J, et al. Chart reviews in emergency medicine research: Where are the methods? Ann Emerg Med 1996;27:305-8.